Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 36 (4) , 719-734
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesBlood, 2012
- Eosinophils as a Novel Cell Source of Prostaglandin D2: Autocrine Role in Allergic InflammationThe Journal of Immunology, 2011
- Evidence for distinct histologic profile of nasal polyps with and without eosinophiliaThe Laryngoscope, 2011
- Eosinophils: Offenders or General Bystanders in Allergic Airway Disease and Pulmonary Immunity?Journal of Innate Immunity, 2011
- Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptorJournal of Experimental Medicine, 2009
- Functional recognition of a distinct receptor preferential for leukotriene E4in mice lacking the cysteinyl leukotriene 1 and 2 receptorsProceedings of the National Academy of Sciences, 2008
- Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentiallyJournal of Leukocyte Biology, 2008
- CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene–dependent mitogenic responses of mast cellsBlood, 2007
- Concordant Modulation of Cysteinyl Leukotriene Receptor Expression by IL-4 and IFN-γ on Peripheral Immune CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Expression of 5‐lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin‐intolerant asthmaThe Journal of Pathology, 2006